8–9 JuneBasel, Switzerland


Host Sponsor



...to Biotech Outsourcing Strategies Basel 2022

Launched in 2006 by Bio2Business Ltd, the Biotech Outsourcing Strategies Events bring together stakeholders in R&D outsourcing to share experience, build existing outsourcing partnerships and forge new buyer/supplier business relationships. The established BOS Formula is built on 4 key pillars; Exhibition showcasing international CROs and CMOs; High Quality Content (delivered through the multi-stream programme); 1-to-1 Partnering; Informal Networking (BOS Events are known for being friendly, intimate events, which create the perfect conditions for networking!).

Since 2016 we are pleased to call Basel our home of our summer event. Located in the heart of Europe, Basel is a unique Life Science Ecosystem which we are proud to support. BOS Basel 2022 will cover Discovery Outsourcing, Small Molecule CMC Outsourcing and Biologics CMC Outsourcing.

Covid Policy: click here to read the latest on Covid guidelines.

Badge QR Code: A QR code will be sent to you on Thursday 4th June and a reminder email sent with the same QR Code on Tuesday 7th June. Please have this QR code ready to present when you arrive at the venue so that your badge can be printed without delay. Contact Bio2Business if you have not received your badge given the schedule outlined herein.

Book your accommodation at BOS Basel 2022 by clicking here.

View Exhibition Floor plan

Important checklist for Sponsors

Important checklist for Exhibition Sponsors

Follow us on LinkedIn to see our latest announcements

Featured Speaker (BOS Basel 2022)

photo of Mr Martin Bates

Crystallisation Strategies for Particle Size Control and Modification

Mr Martin Bates, Solid Form Scientist, Johnson Matthey - Cambridge

ABSTRACT: Click here to Read More

Featured Company (BOS Basel 2022)

Logo for IDT Biologika
IDT Biologika
IDT Biologika is a global biopharmaceutical contract development and manufacturing organization that specializes in the production of innovative vaccines, viral vectors for gene & immune therapeutics, oncolytic viruses, protein-based vaccines including virus-like particles and other sterile liquid and...
View profile